Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
6.68
+1.91 (40.04%)
At close: Dec 20, 2024, 4:00 PM
6.90
+0.22 (3.29%)
After-hours: Dec 20, 2024, 7:55 PM EST
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $4.27 million as of December 20, 2024. Its market cap has decreased by -81.43% in one year.
Market Cap
4.27M
Enterprise Value
11.57M
1-Year Change
-81.43%
Ranking
Category
Stock Price
$6.68
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $4.27M, a decrease of -92.70%. That is a compound annual growth rate of -56.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 4.27M | -81.91% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Windtree Therapeutics | 2.95M |
| iSpecimen | 2.94M |
| Quoin Pharmaceuticals | 2.92M |
| Scinai Immunotherapeutics | 2.90M |
| LogicMark | 2.88M |
| Matinas BioPharma Holdings | 2.85M |
| ZyVersa Therapeutics | 2.79M |
| ENDRA Life Sciences | 2.71M |